Kathryn Mikkelsen on The Beat: Vasculearn Network’s Newsletter for Clot Survivors
Kathryn Mikkelsen, Executive Director at Vasculearn Network, shared on LinkedIn:
”Ever find yourself thinking, “I wish there were a great, free resource I could point my patient—or a family member or friend—to” after a diagnosis of a vascular health condition—such as a blood clot, high cholesterol, atrial fibrillation, or stroke?
That’s exactly why we created The Beat, Vasculearn Network‘s free newsletter for patients, caregivers, and anyone interested in vascular health.
It’s designed to support people after a diagnosis, as well as those looking to better understand vascular conditions and their care.
The Beat covers timely, practical topics in vascular health, offering clear, patient-centered education that clinicians can confidently share beyond the clinic visit.
It’s easy to share and easy to access:
• Available in print
• Read online
• Or listened to directly on our website
If you’re looking for a simple way to extend education beyond the clinic—or to support someone you care about—this is a great place to start.
Sign up or share here.”
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin